Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients with Newly Diagnosed Glioblastoma

Drug Resistant Immunotherapy with gamma delta modified T cells to be resistance to temozolomide will be infused into the surgical cavity following the completion of standard concurrent radiation and chemotherapy with temozolomide.